Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
immune-resistance
Press Release
Mar 12, 2021
Apeximmune Therapeutics Inc. Completes $6 Million Pre-A Series Financing
Develop antibodies against new, next generation targets involved in cancer immune modulation
Read More
First
Prev
1
Next
Last